Development and validation of a [(18)F]FDG PET/CT-based radiomics nomogram to predict the prognostic risk of pretreatment diffuse large B cell lymphoma patients

OBJECTIVE: In this study, based on PET/CT radiomics features, we developed and validated a nomogram to predict progression-free survival (PFS) for cases with diffuse large B cell lymphoma (DLBCL) treated with immunochemotherapy. METHODS: This study retrospectively recruited 129 cases with DLBCL. Amo...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Mingshan, Yao, Hongyang, Zhang, Peng, Zhang, Lingbo, Liu, Wei, Jiang, Zhiyun, Li, Wei, Zhao, Shu, Wang, Kezheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Nuclear Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121518/
https://www.ncbi.nlm.nih.gov/pubmed/36547676
http://dx.doi.org/10.1007/s00330-022-09301-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121518/
https://www.ncbi.nlm.nih.gov/pubmed/36547676
http://dx.doi.org/10.1007/s00330-022-09301-5

Ejemplares similares